(Reuters) - China fined GlaxoSmithKline Plc (GSK.L) a record 3 billion yuan ($489 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drugmaker.

A court in the southern city of Changsha handed suspended jail sentences to Mark Reilly, the former head of GSK in China, and four other GSK executives of between two and four years, according to state news agency Xinhua.

Briton Reilly, shown on state television wearing a suit and looking tired during the trial, will be deported, a source with direct knowledge of the case said.

The verdict, handed out behind closed doors in a single-day trial, highlights how Chinese regulators are increasingly cracking down on corporate malpractice.

More Here: http://www.reuters.com/article/2014/09/19/us-gsk-china-idUSKBN0HE0T...

Views: 61

Replies to This Discussion

The fines are just a slap on the wrist and they will continue business as usual.

They did get jail sentences too, however shortened. "A court in the southern city of Changsha handed suspended jail sentences to Mark Reilly, the former head of GSK in China, and four other GSK executives of between two and four years, according to state news agency Xinhua."

You wouldn't see that happen in the US. Every Institution, from big Government down to public schools are in bed with Big Pharma. :(

They need some serious prison time to really get the message.

I agree... to set the precedent. Big pharma drug pushers should be treated just like big crack cocaine or heroine dealers are dealt with. More often than not, they get a harsh sentence for pushing their poisons.

RSS

Photos

Loading…
  • Add Photos
  • View All

Please remember this website is supported by your donations...

© 2017   Created by truth.   Powered by

Badges  |  Report an Issue  |  Terms of Service

content and site copyright 12160.info 2007-2015 - all rights reserved. unless otherwise noted